Suivre
Shahab Asgharzadeh
Titre
Citée par
Citée par
Année
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ...
Nature genetics 45 (3), 279-284, 2013
11672013
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ...
Nature genetics 47 (8), 864-871, 2015
5352015
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
W Zhang, Y Yu, F Hertwig, J Thierry-Mieg, W Zhang, D Thierry-Mieg, ...
Genome biology 16, 1-12, 2015
3922015
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy
KB Challagundla, PM Wise, P Neviani, H Chava, M Murtadha, T Xu, ...
Journal of the National Cancer Institute 107 (7), djv135, 2015
3682015
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
L Song, S Asgharzadeh, J Salo, K Engell, H Wu, R Sposto, T Ara, ...
The Journal of clinical investigation 119 (6), 1524-1536, 2009
3412009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
M Capasso, M Devoto, C Hou, S Asgharzadeh, JT Glessner, EF Attiyeh, ...
Nature genetics 41 (6), 718-723, 2009
3362009
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
JM Maris, YP Mosse, JP Bradfield, C Hou, S Monni, RH Scott, ...
New England Journal of Medicine 358 (24), 2585-2593, 2008
3132008
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
S Asgharzadeh, JA Salo, L Ji, A Oberthuer, M Fischer, F Berthold, ...
Journal of Clinical Oncology 30 (28), 3525, 2012
2852012
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa, HW Wu, H Wang, Y Yang, Z Warsi, S Asgharzadeh, ...
The Journal of experimental medicine 199 (9), 1213-1221, 2004
2712004
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification
S Asgharzadeh, R Pique-Regi, R Sposto, H Wang, Y Yang, H Shimada, ...
Journal of the National Cancer Institute 98 (17), 1193-1203, 2006
2512006
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome
M Hölzel, S Huang, J Koster, I Øra, A Lakeman, H Caron, W Nijkamp, ...
Cell 142 (2), 218-229, 2010
2252010
Revised neuroblastoma risk classification system: a report from the Children's Oncology Group
MS Irwin, A Naranjo, FF Zhang, SL Cohn, WB London, JM Gastier-Foster, ...
Journal of Clinical Oncology 39 (29), 3229, 2021
2082021
Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous …
SL Gardner, S Asgharzadeh, A Green, B Horn, G McCowage, J Finlay
Pediatric blood & cancer 51 (2), 235-240, 2008
1622008
Sparse representation and Bayesian detection of genome copy number alterations from microarray data
R Pique-Regi, J Monso-Varona, A Ortega, RC Seeger, TJ Triche, ...
Bioinformatics 24 (3), 309-318, 2008
1612008
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed …
J Fangusaro, J Finlay, R Sposto, L Ji, M Saly, S Zacharoulis, ...
Pediatric blood & cancer 50 (2), 312-318, 2008
1582008
Cancer-associated fibroblasts share characteristics and protumorigenic activity with mesenchymal stromal cells
L Borriello, R Nakata, MA Sheard, GE Fernandez, R Sposto, J Malvar, ...
Cancer research 77 (18), 5142-5157, 2017
1552017
CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus
MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ...
Cancer research 75 (15), 3155-3166, 2015
1552015
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome
S Huang, J Laoukili, MT Epping, J Koster, M Hölzel, BA Westerman, ...
Cancer cell 15 (4), 328-340, 2009
1542009
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
D Liu, L Song, J Wei, AN Courtney, X Gao, E Marinova, L Guo, A Heczey, ...
The Journal of clinical investigation 122 (6), 2221-2233, 2012
1492012
Prognostic impact of gene expression–based classification for neuroblastoma
A Oberthuer, B Hero, F Berthold, D Juraeva, A Faldum, Y Kahlert, ...
Journal of Clinical Oncology 28 (21), 3506-3515, 2010
1412010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20